Expression of Syndecan-1 in histologically normal breast tissue from postmenopausal women with breast cancer according to mammographic density

Climacteric

Volumn 9, Issue 4, 2006, Pages 277-282

  Lundstrom E ^a   Sahlin, L ^a   Skoog, L ^a   Hagerstrom T ^a   Svane, G ^a   Azavedo, E ^a   Sandelin, K ^a   Von Schoultz, B ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Breast stroma; Mammographic breast density; Proteoclycans; Syndecan 1

Indexed keywords

ESTROGEN RECEPTOR; RECEPTOR SUBTYPE; SYNDECAN 1;

ADULT; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAMMOGRAPHY; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE DIAGNOSIS; RADIODIAGNOSIS;

BREAST; BREAST NEOPLASMS; EPITHELIUM; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MAMMOGRAPHY; MIDDLE AGED; POSTMENOPAUSE; STROMAL CELLS; SYNDECAN-1; TISSUE DISTRIBUTION;

EID: 33746649108     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.1080/13697130600865741     Document Type: Article

References (29)

1. Boyd NF, Rommens JM, Vogt K, et al. Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol 2005;6:798-808
2. Harvey J, Bovbjerg V. Quantitative assessment of mammographic breast density: relationship with breast cancer risk. Radiology 2004;230:29-41
3. Boyd NF, Stone J, Martin LJ, et al. The association of breast mitogens with mammographic densities. Br J Cancer 2002;87:876-82
4. Lundström E, Wilczek B, von Palffy Z, Söderqvist G, von Schoultz B. Mammographic breast density during hormone replacement therapy: differences according to treatment. Am J Obstet Gynecol 1999;181:348-52
5. Lundström E, Christow A, Kersemaekers W, et al. Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast density. Am J Obstet Gynecol 2002;186:717-22
6. Warren R. Hormones and mammographic breast density. Maturitas 2004;49:67-78
7. Boyd NF, Jensen HM, Cooke G, Han HL, Lockwood GA, Miller AB. Mammographic densities and the prevalence and incidence of histological types of benign breast disease. Eur J Cancer Prev 2000;9:15-24
8. Heijne JJ, Malhotra P. Mammographic tissue breast cancer risk, serial image analysis, and digital mammography. 1. Tissue and related risk factors. Acad Radiol 2002;9:298-316
9. Guo Y-P, Martin L, Hanna W, et al. Growth factors and stromal matrix proteins associated with mammographic densities. Cancer Epidemiol Biomark Prev 2001;10:243-8
10. Alowami S, Troup S, Al-Haddad S, Kirkpatrick I, Watson P. Mammographic density is related to stroma and stromal proteoglycan expression. Breast Cancer Res 2003;5:129-35
11. Woodward L, Xie JW, Haslam SZ. The role of mammary stroma in modulating the proliferative response in the normal mammary gland. J Mammary Gland Biol Neoplasia 1998;3:117-31
12. Delehedde M, Lyon M, Sergeant N, Rahmoune H, Fernig DG. Proteoglycans: pericellular and cell surface multireceptors that integrate external stimuli in the mammary gland. J Mammary Gland Biol Neoplasia 2001;6:253-73
13. Beauvais DLM, Rapraeger A. Syndecans in tumour cell adhesion and signaling. Reprod Biol Endocrinol 2004;2:1-12
14. Roskelly CD, Bissell MJ. Dynamic reciprocity revisited: a continuous, bidirectional flow of information between cells and the extra cellular matrix regulates mammary epithelial cell function. Biochem Cell Biol 1995;73:391-7
15. Barbareschi M, Maisonneuve P, Aldovini D, et al. High Syndecan-1 expression in breast carcinoma is related to aggressive phenotype and to poorer prognosis. Cancer 2003;1:474-83
16. Levionen M, Lundin J, Nordling S, von Boguslawski K, Haglund C. Prognostic value of Syndecan-1 expression in breast cancer. Oncology 2004;67:11-18
17. Stanley MJ, Stanley MW, Sanderson RD, Zera R. Syndecan-1 expression is induced in the stroma of infiltrating breast carcinoma. Am J Clin Pathol 1999;112:377-83
18. Maeda T, Alexander C, Friedi A. Induction of Syndecan-1 expression in stromal fibroblasts promotes proliferation of human breast cancer cells. Cancer Res 2004;64:612-21
19. Södergård R, Bäckström T, Shanbhag V, Carstensen H. Calculation of free and bound fractions of testosterone and estradiol-17beta to human plasma proteins at body temperature. J Steroid Biochem 1982;16:801-10
20. Wu X, Pang ST, Sahlin L, Blanck A, Norstedt G, Flores-Morales A. Gene expression profiling of the effects of castration and estrogen treatment in the rat uterus. Biol Reprod 2003;69:1308-17
21. Boyd NF, Dite GS, Stone J, et al. Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med 2002;347:886-94
22. Ziv E, Tice J, Smith-Bindman R, Shepherd J, Cummings S, Kerlikowske K. Mammographic density and estrogen receptor status of breast cancer. Cancer Epidemiol Biomarkers Prev 2004;13:2090-5
23. van Duijnhoven FJ, Bezemer ID, Peeters PH, et al. Polymorphisms in the estrogen receptor alpha gene and mammographic density. Cancer Epidemiol Biomarkers Prev 2005;14:2655-60
24. Conner P. Hormone therapy and the breast - aspects on proliferation, apoptosis and mammographic density. Doctoral Thesis, Karolinska Institute, Stockholm, 2004
25. Lundström E, Söderqvist G, Svane G, et al. Digitized assessment of mammographic breast density during low dose intrauterine levonorgestrel in continuous combination with oral estradiol valerate. A pilot study. Fertil Steril 2006;85:989-95
26. Conner P, Söderqvist G, Skoog L, et al. Breast cell proliferation in postmenopausal women during HRT evaluated through fine needle aspiration cytology. Breast Cancer Res 2003;78:159-65
27. Shekar M, Pauley R, Heppner G. Extracellular matrix-stromal cell contribution to neoplastic phenotype of epithelial cells in the breast. Breast Cancer Res 2003;5:130-5
28. Imagawa W, Pedchenko VK, Helber J, Zhang H. Hormone/growth factors interactions mediating epithelial/stromal communication in mammary gland development and carcinogenesis. J Steroid Biochem Mol Biol 2002;80:213-30
29. Bernfield M, Gotte M, Park PW, et al. Functions of cell surface heparan sulphate proteoglycan. Annu Rev Biochem 1999;68:727-77